Inaktiver Wert

Andere Sprachen Altimmune Inc Nyse

Aktien

US71714G1022

Schlusskurs Nyse Andere Börsenplätze
- ^USD	-

09.05.	Altimmune, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
29.04.	Altimmune-Aktien sinken nach Herabstufung durch Guggenheim	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Altimmune Inc. to Contact Law Firm	09.05.
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors	09.05.
Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000	09.05.
Altimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update	09.05.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALT	09.05.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	08.05.
ALT Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	08.05.
Law Offices of Howard G. Smith Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	08.05.
The Law Offices of Frank R. Cruz Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	07.05.
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALT	07.05.
Altimmune to Participate at Two Upcoming Investor Conferences	07.05.
Pomerantz Law Firm Announces the Filing of a Class Action Against Altimmune, Inc. and Certain Officers - ALT	07.05.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune	06.05.
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	02.05.
Altimmune to Participate at Two Upcoming Conferences	01.05.
North American Morning Briefing : More Earnings -2-	30.04.
Altimmune Shares Decline After Guggenheim Downgrade	29.04.
Altimmune Statement on the Passing of Dr. Stephen Harrison	25.04.
Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B	27.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Altimmune Inc Nyse

Aktien

US71714G1022

Andere Sprachen

Filter